Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms

计划入组 164 人 · 首次发布于 2026 年 1 月 29 日

The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients

计划入组 570 人 · 首次发布于 2024 年 1 月 12 日

Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms

计划入组 140 人 · 首次发布于 2026 年 1 月 28 日

Anti-CD34 mab-sirolimus (OrbusNeich)

Marburg vaccine(Flow Pharma)

Ebola vaccine (Flow Pharma)

Flow Neuroscience AB

Sweden

Artivion

United States

InspireMD

Oxford Heartbeat Completes Patient Recruitment for AI-Powered PreSize Neurovascular Software Trial

Peijia Medical Achieves First-Ever Profit Before Tax on Strong TAVR Growth

Innovative Neck Stent in Clinical Trials Shows Promise in Stroke Prevention